1 study found for:    "NJMS" OR "New Jersey Medical School" | Open Studies | "Carcinoma, Renal Cell"
Show Display Options
Rank Status Study
1 Recruiting Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma;   Recurrent Renal Cell Cancer;   Stage III Renal Cell Cancer;   Stage IV Renal Cell Cancer
Interventions: Biological: ziv-aflibercept;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years